Low Bone Strength and Mass Associated With Increased Risk for Major Adverse Coronary Events in Older Men
In this study, researchers assess the connection between bone fragility and major adverse coronary events in older men.
Bone Metabolism
Vitamin D Supplementation May Lead to Small Risk Reduction for Acute Respiratory Infections
Iin this study published in The Lancet Diabetes and Endocrinology, researchers evaluated whether the effects of vitamin D supplementation may reduce risk in acute respiratory infections.
Osteoporosis Prevalence at Femur Neck, Lumbar Spine 12.3%
The age-adjusted prevalence of osteoporosis at either the femur neck or lumbar spine or both was 12.6% among adults aged 50 years and older in 2017 to 2018.
Evidence, Primary Considerations for Bisphosphonate Drug Holidays in Patients With Osteoporosis
Authors of the review discuss primary considerations and areas for future research regarding bisphosphonate drug holiday duration in patients with osteoporosis.
ASBMR, AACE, NOF Develop Joint Guidance on COVID-19 Vaccination and Osteoporosis Management
ASBMR, AACE, Endocrine Society, ECTS, IOF, and NOF developed guidance on COVID-19 vaccination and osteoporosis management.
Factors Associated With Fracture Risk in Middle Age Identified
Several factors have been identified that increase the likelihood of experiencing a fracture in middle age, including female sex and a low level of leisure-time physical activity.
AFF Risk Increases With Bisphosphonate Use, Decreases Upon Discontinuation
In this study, researchers used electronic health records to study fracture radiographs of women aged >50 years to evaluate risk factors for AFF associated with long-duration bisphosphonate treatment.
Sydney AFF Score Quickly and Accurately Detects Atypical Femur Fractures in Women
The Sydney AFF Score is a tool to help differentiate atypical from typical femur fractures in women, independent of bisphosphonate use.
Men With Diffuse Idiopathic Skeletal Hyperostosis at Higher Risk for Vertebral Fractures
The objective of this study was to analyze the risk of incident vertebral and nonvertebral fracture in men with DISH.
Risks After Denosumab Discontinuation Linked to Age and Prior Therapy
Researchers sought to identify potential vertebral fracture and bone loss risk factors after discontinuation of denosumab therapy and initiation of other therapy.
-
Loading...
-
Loading...
Next post in Bone Metabolism
